Introduction to Lumakras (Sotorasib) 120mg
Lumakras (Sotorasib) 120mg is a targeted prescription medicine used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) with specific genetic mutations. This medicine belongs to a modern class of oncology drugs known as targeted cancer therapies that act directly on cancer-driving mutations.
Lumakras (Sotorasib) 120mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapies. It contains Sotorasib, which works by specifically inhibiting mutated KRAS G12C proteins responsible for uncontrolled cancer cell growth.
In some markets, Sotoxen 120mg is available as a generic brand containing the same active ingredient Sotorasib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.
What Is Lumakras (Sotorasib)?
Lumakras is the original brand name for Sotorasib, an oral medication used for treating cancers driven by KRAS G12C mutation.
Sotorasib belongs to a class of medicines known as KRAS inhibitors, a type of targeted therapy designed to block specific cancer-causing proteins.
Generic versions such as Sotoxen 120mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Sotorasib is classified as a targeted therapy and KRAS G12C inhibitor with strong antineoplastic properties.
How Sotorasib Works
It works in several ways:
- Specifically targets KRAS G12C mutated proteins in cancer cells
- Blocks signals responsible for tumor cell growth and survival
- Helps stop the spread and progression of cancer
Through these mechanisms, Sotorasib helps slow or stop the progression of certain cancers.
How Lumakras Works in the Body
Cancer cells with KRAS mutations grow uncontrollably due to continuous signaling. Lumakras helps block these signals and restore controlled cell behavior.
Key Actions of Sotorasib
- Inhibiting KRAS G12C signaling pathways
- Preventing cancer cell proliferation
- Promoting cancer cell death (apoptosis)
Some generic versions such as Sotoxen deliver the same active compound, allowing similar targeted cancer treatment when prescribed appropriately.
Medical Uses of Lumakras (Sotorasib) 120mg
Lumakras 120mg is prescribed for specific cancers associated with KRAS mutations.
Lumakras for Non-Small Cell Lung Cancer (NSCLC)
It is primarily used for patients with KRAS G12C-mutated NSCLC who have received prior treatments.
Potential Benefits
- Targeted action on cancer mutation
- Improved disease control
- Slowing tumor progression
Generic alternatives like Sotoxen 120mg may also be used under medical supervision when Sotorasib therapy is recommended.
Who Can Take Sotoxen 120mg?
Because Sotorasib is a specialized medicine, treatment should always be supervised by an experienced healthcare provider.
Eligibility Criteria
Patients may be prescribed Lumakras if they:
- Have confirmed KRAS G12C mutation-positive cancer
- Are diagnosed with NSCLC or related cancers
- Have received prior systemic therapy
Certain generic options such as Sotoxen may also be considered depending on availability and physician decision.
Who Should Avoid Lumakras (Sotorasib) 120mg
Lumakras should NOT be used by:
- Individuals with hypersensitivity to Sotorasib
- Patients with severe liver impairment without medical supervision
- Pregnant or breastfeeding women unless advised by a doctor
Lumakras (Sotorasib) 120mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Lumakras 120mg tablets as prescribed by oncologist
- Usually taken orally once daily
- Swallowed whole with water
- Can be taken with or without food
Dosage Adjustments
Doctors may adjust the dose depending on:
- Liver function
- Treatment response
- Side effects experienced
Side Effects of Lumakras 120mg
Like all cancer medicines, Lumakras may cause side effects.
Common Side Effects
- Diarrhea
- Fatigue
- Nausea
- Liver enzyme abnormalities
Serious Side Effects
- Liver toxicity (hepatotoxicity)
- Interstitial lung disease (ILD)
- Severe gastrointestinal issues
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Lumakras (Sotorasib) 120mg safe for long-term use?
Treatment duration depends on patient response and tolerance, under continuous medical supervision.
2. Is Lumakras used as chemotherapy?
No. It is a targeted therapy that specifically inhibits KRAS G12C mutation rather than traditional chemotherapy.
3. Can Lumakras cure lung cancer?
It is not a cure but helps control disease progression and improve outcomes.
4. Can patients take Sotoxen 120mg instead of Lumakras?
Sotoxen 120mg contains the same active ingredient Sotorasib and may be used if prescribed by a doctor.
5. Can pregnant women take Sotoxen 120mg?
No. It should only be used if clearly advised by a healthcare professional due to potential risks.
6. Is Sotoxen 120mg the same as Lumakras?
Sotoxen 120mg contains Sotorasib, the same active ingredient found in Lumakras. Generic versions is available.
7. Do I need a prescription to buy Sotoxen (Sotorasib) 120mg?
Yes. It is a prescription-only medicine and must be used under medical supervision.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Lumakras (Sotorasib) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.
